Literature DB >> 16723461

Experimental glaucoma and optic nerve transection induce simultaneous upregulation of proapoptotic and prosurvival genes.

Hani Levkovitch-Verbin1, Rima Dardik, Shelly Vander, Yael Nisgav, Maya Kalev-Landoy, Shlomo Melamed.   

Abstract

PURPOSE: To investigate changes in gene expression induced by elevated intraocular pressure (IOP) and complete optic nerve transsection (ONT) over time.
METHODS: A gene array of 18 signal transduction pathways was used to examine the changes in RNA profiles of retinas post-ONT in rats. Among the seven genes that were determined to be upregulated, four were confirmed to have higher expression by semiquantitative RT-PCR analysis: Ei24 and Gadd45a (both associated with apoptosis induced via the p53 pathway), IAP-1 (inhibitor of apoptosis protein 1), and Cdk2 (cell cycle regulation and apoptosis). Their mRNA levels were then studied by quantitative RT-PCR in experimental glaucoma and ONT over time. Levels of the corresponding proteins were evaluated by Western blot analysis and immunohistochemistry.
RESULTS: Proapoptotic genes from the p-53 pathway (Ei24 and Gadd45a), Cdk2 and the prosurvival gene IAP-1 (a caspase inhibitor) were simultaneously and significantly upregulated early after ONT, returning to baseline at 2 weeks. In experimental glaucoma, Gadd45a was significantly upregulated 1 week after induction of increased IOP and stayed upregulated for 2 months and long after IOP returned to baseline. The prosurvival gene IAP-1 was simultaneously upregulated but returned to baseline earlier than the proapoptotic gene. Ei24 and Cdk2 were only slightly upregulated in glaucoma. Western blot analysis demonstrated upregulation of Gadd45a and IAP-1 proteins. Immunohistochemistry localized these changes to the retinal ganglion cell layer.
CONCLUSIONS: Members of the p-53 signal transduction pathway are significantly involved in glaucoma and ONT. The endogenous caspase inhibitor IAP-1 is upregulated simultaneously, possibly as part of an intrinsic neuroprotective mechanism. Changes in glaucoma are gradual and last long after IOP returns to normal.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16723461     DOI: 10.1167/iovs.05-0996

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  21 in total

1.  Minocycline upregulates pro-survival genes and downregulates pro-apoptotic genes in experimental glaucoma.

Authors:  Hani Levkovitch-Verbin; Yael Waserzoog; Shelly Vander; Daria Makarovsky; Ilia Piven
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-25       Impact factor: 3.117

Review 2.  Differential gene expression in glaucoma.

Authors:  Tatjana C Jakobs
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

3.  Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma.

Authors:  Anitha Krishnan; Fei Fei; Alexander Jones; Patricia Busto; Ann Marshak-Rothstein; Bruce R Ksander; Meredith Gregory-Ksander
Journal:  J Immunol       Date:  2016-11-14       Impact factor: 5.422

4.  Similarities and differences between primary and secondary degeneration of the optic nerve and the effect of minocycline.

Authors:  Hani Levkovitch-Verbin; Oriel Spierer; Shelly Vander; Rima Dardik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-13       Impact factor: 3.117

Review 5.  Pharmacological neuroprotection for glaucoma.

Authors:  Glyn Chidlow; John P M Wood; Robert J Casson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  A dietary combination of omega-3 and omega-6 polyunsaturated fatty acids is more efficient than single supplementations in the prevention of retinal damage induced by elevation of intraocular pressure in rats.

Authors:  Coralie Schnebelen; Bruno Pasquis; Manuel Salinas-Navarro; Corinne Joffre; Catherine P Creuzot-Garcher; Manuel Vidal-Sanz; Alain M Bron; Lionel Bretillon; Niyazi Acar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-13       Impact factor: 3.117

7.  Effect of CNTF on retinal ganglion cell survival in experimental glaucoma.

Authors:  Mary Ellen Pease; Donald J Zack; Cynthia Berlinicke; Kristen Bloom; Frances Cone; Yuxia Wang; Ronald L Klein; William W Hauswirth; Harry A Quigley
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-05       Impact factor: 4.799

Review 8.  Glaucomatous neurodegeneration: an eye on tumor necrosis factor-alpha.

Authors:  Renu Agarwal; Puneet Agarwal
Journal:  Indian J Ophthalmol       Date:  2012-07       Impact factor: 1.848

9.  The p53 codon 72 PRO/PRO genotype may be associated with initial central visual field defects in caucasians with primary open angle glaucoma.

Authors:  Janey L Wiggs; Alex W Hewitt; Bao Jian Fan; Dan Yi Wang; Dayse R Figueiredo Sena; Colm O'Brien; Anthony Realini; Jamie E Craig; David P Dimasi; David A Mackey; Jonathan L Haines; Louis R Pasquale
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

10.  Common variants on chromosome 9p21 are associated with normal tension glaucoma.

Authors:  Mitsuko Takamoto; Toshikatsu Kaburaki; Akihiko Mabuchi; Makoto Araie; Shiro Amano; Makoto Aihara; Atsuo Tomidokoro; Aiko Iwase; Fumihiko Mabuchi; Kenji Kashiwagi; Shiroaki Shirato; Noriko Yasuda; Hidetoshi Kawashima; Fumiko Nakajima; Jiro Numaga; Yoshiya Kawamura; Tsukasa Sasaki; Katsushi Tokunaga
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.